News

Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective ...
The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...
Bonus Biogroup (TASE: BONS), a late-stage biotechnology company priming immunomodulatory and regenerative mesenchymal stem cells (MSC) to develop novel tissue engineering and cell therapy solutions, ...
The Department of Education (DepEd) vowed to extend its full cooperation with the Office of the Ombudsman following the ...
Neural stem cell treatment was safe and significantly boosted myelin repair in spinal cord lesions in a mouse model of MS, ...